Systematic in‐hospital screening and treatment for osteoporosis in a geriatric population with hip fractures
Journal of Hospital Medicine · 2025
DOI: 10.1002/jhm.70036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hospital Medicine, 2025. Verfasst von Jeppe B Rosenbæk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gødstrup Hospital, Herning, Denmark. Hauptthemen laut MEDLINE: Hip Fractures, Osteoporosis, Bone Density Conservation Agents, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Danish Diabetes Academy, Novo Nordisk Foundation, Grant/Award Number: NNF17SA0031406.
Abstract (Originalsprache)
Background
Low‐trauma fractures of the hip signify osteoporosis and increase the risk of a second fracture. However, screening for secondary osteoporosis and initiating osteoporosis treatment can be challenging in a geriatric population.
Objectives
To investigate an in‐hospital approach to secure treatment, screening and follow‐up of osteoporosis.
Methods
We evaluated the feasibility of a clinical approach to osteoporosis treatment with in‐hospital zoledronic acid (ZOL) infusion, screening for secondary osteoporosis, and dual‐energy X‐ray absorptiometry (DXA) with a vertebral fracture assessment (VFA) in a cohort of 128 patients. We compared this cohort to a historic cohort of 135 patients, where screening and treatment were provided by general practice.
Results
In the intervention cohort, 58% of the patients received anti‐osteoporosis treatment within 6 months of admission. Forty‐eight patients (38%) received ZOL during admission, while nine continued their usual treatment. An additional 17 patients received ZOL or another anti‐osteoporosis treatment within 6 months. The most common reasons for not receiving ZOL were vitamin D deficiency (24%) and renal impairment (7%). In total, 35% ( n = 43) had a DXA within 6 months of admission; VFA revealed nine cases of vertebral fractures. Screening for secondary osteoporosis revealed vitamin D deficiency with and without secondary hyperparathyroidism (48%) and subclinical hyperthyroidism (8%) as the most common findings. Together, biochemical screening and VFA changed the treatment strategy in less than five cases.
Conclusion
Administering ZOL in‐hospital following a hip fracture in combination with a systematic follow‐up secured treatment in 6 out of 10 patients. However, compliance with DXA was low, which might not be of major concern, since DXA only individualized treatment in a few patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Gødstrup Hospital, Herning, Denmark.
- Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
- Danish Diabetes Academy, Odense University Hospital, Odense, Denmark.
Förderung
- Danish Diabetes Academy
- Novo Nordisk Foundation, Grant/Award Number: NNF17SA0031406
Zitieren
APA
Rosenbæk, J. B., Dalgaard, L. B., Grauballe, A., Wilfred, S. J., Ibsen, M. W., & Madsen, L. R. (2025). Systematic in‐hospital screening and treatment for osteoporosis in a geriatric population with hip fractures. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.70036
Vancouver
Rosenbæk JB, Dalgaard LB, Grauballe A, Wilfred SJ, Ibsen MW, Madsen LR. Systematic in‐hospital screening and treatment for osteoporosis in a geriatric population with hip fractures. Journal of Hospital Medicine. 2025. doi:10.1002/jhm.70036
BibTeX
@article{Rosenbk2025,
author = {Rosenbæk, Jeppe B and Dalgaard, Line B and Grauballe, Anne and Wilfred, Stella J and Ibsen, Mikkel W and Madsen, Lene R},
title = {Systematic in‐hospital screening and treatment for osteoporosis in a geriatric population with hip fractures},
journal = {Journal of Hospital Medicine},
year = {2025},
doi = {10.1002/jhm.70036}
}
EUVIMED